Products
-
- BBB DamageCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Tetramethylrhodamine isothiocyanate Isomer R (AC209)
Cat.#: ASSD-209
Specifications
Description Tetramethylrhodamine isothiocyanate Isomer R is an amine-reactive fluorescent probe useful in the fluorescent labeling of proteins or peptides. Also widely used in the labelling of proteins. Synonyms 6-TRITC, R-isomer Size 5 mg, 10 mg Applications An amine reactive fluorescent label Molecule Weight 443.52 Molecular formula C25H21N3O3S CAS Number 80724-20-5 MDL Number MFCD00063517 Solubility soluble in 1M NH4OH in MeOH Form Powder Storage Store at 4° C Shipping Shipped at 4°C Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Size Price ASSD-149 D-Luciferin sodium salt (AC149) 10 mg, 50 mg, 100 mg inquiry ASSD-143 Fluorescently labeled Muscimol TMR-X conjugate (AC143) 1mg inquiry ASSD-112 Propidium Iodide Staining Solution (1mg/ml) in water (AC112) 1 mL inquiry ASSD-151 Acid Fuchsin (AC151) 25 g inquiry ASSD-179 8-Azidoadenosine-5′-diphosphate Sodium Salt (AC179) 1 mg, 5 mg inquiry ASSD-116 Annexin V-FITC Apoptosis Staining / Detection Kit (AC116) 1 kit, 100 tests inquiry ASSD-223 Antifade Fluorescence Mounting Medium (aqueous) (AC223) 10 mL inquiry ASSD-136 LUF7445/A2A antagonist (AC136) 50 μg inquiry ASSD-187 Quinaldine Red (AC187) 5 g, 25 g, 100 g, 250 g inquiry ASSD-175 5-Carboxyfluorescein-N-hydroxysuccinimide Ester (AC175) 25 mg inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
0Inquiry Basket